1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, January 2017 (p2)

Biological Therapy Analysis & Statistics, January 2017 (p2)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

31-60 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

2017-2021 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2017-2021 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • January 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
Hemagglutinin 5 (H5) - Pipeline Review, H2 2016

Hemagglutinin 5 (H5) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Hemagglutinin 5 (H5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hemagglutinin 5 (H5) - Pipeline Review, H2 2016’, provides in depth analysis on Hemagglutinin 5 (H5) targeted pipeline ...

  • Industries : Pathology
  • Countries : United States
Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H2 2016

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, ...

  • Industries : Cancer, Pathology, Biological Therapy, Therapy
  • Countries : Europe, World
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2016

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline ...

  • Industries : Biological Therapy, Pathology, Therapy
  • Countries : France, World, United States, Europe
Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H2 2016

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H2 2016 Summary Global ...

  • Industries : Therapy, Pathology, Biological Therapy
  • Countries : United States
Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016

Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin ...

  • Industries : Biological Therapy, Therapy
  • Countries : United States
Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2016

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase ...

  • Industries : Therapy, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : United States, World
Interleukin 15 (IL15) - Pipeline Review, H2 2016

Interleukin 15 (IL15) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Interleukin 15 (IL15) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 15 (IL15) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 15 (IL15) targeted ...

  • Industries : Pathology, Biological Therapy, Therapy
  • Countries : United States, World
US Market Report for Cellular Allografts 2017 - MedCore

US Market Report for Cellular Allografts 2017 - MedCore

  • $ 2995
  • Industry report
  • March 2017
  • by iData Research, Inc.

Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...

  • Industries : Biological Therapy
  • Countries : United States
Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts

Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • February 2017
  • by Currentpartnering

Summary The Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine ...

  • Industries : Biological Therapy, Biotechnology, Pharmaceutical, Pathology, Healthcare, Therapy
  • Countries : United States, North America
Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023

Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Growth Hormone Deficiency (GHD)  in seven major markets (US, France, ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017" provides an overview ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, ...

  • Industries : Cancer, Pathology
  • Countries : United States
Liver Cancer - Pipeline Review, H2 2016

Liver Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Liver Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology, Cancer
  • Countries : United States
Parkinson’s Disease - Pipeline Review, H2 2016

Parkinson’s Disease - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Parkinson’s Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Parkinson’s Disease – Pipeline Review, H2 2016, provides ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World
Malignant Mesothelioma Global Clinical Trials Review, H2, 2016

Malignant Mesothelioma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Malignant Mesothelioma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant ...

  • Industries : Cancer, Pathology
  • Countries : World
Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2016

Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Pharmaceutical, Drug Discovery and Development
  • Countries : World
Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2016

Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Bronchiectasis Global Clinical Trials Review, H2, 2016

Bronchiectasis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Bronchiectasis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Bronchiectasis Global Clinical Trials Review, H2, 2016" provides an overview of Bronchiectasis clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Chronic Disease, Therapy, Pathology
  • Countries : World
Cell Therapy Manufacturing Market, 2017-2027

Cell Therapy Manufacturing Market, 2017-2027

  • $ 2499
  • Industry report
  • March 2017
  • by Roots Analysis Private Ltd.

The “Cell Therapy Manufacturing Market, 2017-2027” report provides an extensive study of the rapidly growing market of cell therapy manufacturing and focuses both on contract manufacturers and cell ...

  • Industries : Biological Therapy
  • Countries : United Kingdom
Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis, 2017

Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis, 2017

  • $ 2450
  • Industry report
  • March 2017
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of ...

  • Industries : Biological Therapy, Therapy
T-Cell Immunotherapy Market (2nd Edition), 2017-2030

T-Cell Immunotherapy Market (2nd Edition), 2017-2030

  • $ 2449
  • Industry report
  • January 2017
  • by Roots Analysis Private Ltd.

INTRODUCTION The concept of immunotherapies dates back to the 18th century; however, since inception, the field has evolved tremendously and is currently cited as one of the most rapidly growing segments ...

  • Industries : Biological Therapy, Biotechnology, Pharmaceutical, Therapy
  • Countries : United States
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities

The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities

  • $ 2365
  • Industry report
  • January 2017
  • by La Merie Publishing

The Oncolytic Virus Landscape 2017: an analysis of pipeline,stakeholders, deals, industry trends & opportunities The field of oncolytic viruses wasquite dormant in the first decade of the 2000s, characterized ...

  • Industries : Pathology, Therapy, Cancer
  • Countries : United States
Duchenne Muscular Dystrophy - Pipeline Review, H1 2017

Duchenne Muscular Dystrophy - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Duchenne Muscular Dystrophy - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2017, ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States
Thalassemia - Pipeline Review, H1 2017

Thalassemia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Thalassemia - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Liver Cirrhosis - Pipeline Review, H1 2017

Liver Cirrhosis - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Liver Cirrhosis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Pathology
  • Countries : United States
Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Pipeline Review, ...

  • Industries : Healthcare, Blood Supply, Tissue Banking and Transplantation, Health Facility, Therapy
  • Countries : United States
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.